ASND — ASCENDIS PHARMA A S

Ownership history in WOLVERINE TRADING, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in ASCENDIS PHARMA A S (ASND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 ADDED 13,000 +9,143 +237.0% 0.00% $2.2M $172.60
2023 Q2 ADDED 3,857 +3,841 +24006.2% 0.00% $337K $89.25
2016 Q2 INITIATED 16 — — 0.00% $217 $13.27
% of Fund (quarterly)    ASND price (monthly, adj. close)

Other funds also holding ASND

As of 2025 Q4 — sorted by position size

Q Global Advisors, LLC 3Y 7Y 39.86% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 22.46% Avoro Capital Advisors LLC 3Y 7Y 10.71% Resolute Capital Asset Partners LLC 3Y 9.13% Tri Locum Partners LP 3Y 7.34% WESTFIELD CAPITAL MANAGEMENT CO LP 3Y 7Y 4.61% Catalio Capital Management, LP 4.49% Spyglass Capital Management LLC 3Y 7Y 4.43% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.11% PFM Health Sciences, LP 3Y 7Y 3.78%
← Back to WOLVERINE TRADING, LLC Holdings